Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Runimotamab's trials
A Study of Runimotamab in Participants With Locally Advanced or Metastatic HER2-Expressing Cancers
Runimotamab
Ongoing
Active not recruiting
Phase 1
Open NCT03448042 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
NCT03448042 · Trial Tracker · ComplyRx
